Recent Activity

Loading...

PBE

Invesco Biotechnology & Genome ETF · PSE

  • Category Equity
  • Expense Ratio 0.58%
  • Listing Date Jun 23, 2005
  • Volume 3,736.0
  • Market Cap (AUM) $256.85M

Performance

+0.02%

1W

-0.06%

1M

-0.86%

3M

+18.78%

6M

-3.4%

YTD

+1.33%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Bio-Techne CorporationTECH5.41%
  • Neurocrine Biosciences, Inc.NBIX5.30%
  • Regeneron Pharmaceuticals, Inc.REGN4.98%
  • Amgen Inc.AMGN4.94%
  • Biogen Inc.BIIB4.90%
  • Vertex Pharmaceuticals IncorporatedVRTX4.79%
  • BioMarin Pharmaceutical Inc.BMRN4.75%
  • Gilead Sciences, Inc.GILD4.56%
  • PTC Therapeutics, Inc.PTCT3.55%
  • TG Therapeutics, Inc.TGTX3.41%

Technical Analysis of PBE 2024-05-10

Overview:

In analyzing the provided Technical Analysis (TA) data for the last 5 days of PBE stock, we will delve into the trend, momentum, volatility, and volume indicators to derive insights into the possible future stock price movement. By examining key metrics such as moving averages, MACD, RSI, Stochastic Oscillator, Bollinger Bands, and vol...

See more ...

Recent News & Updates